Skip to main content
[Preprint]. 2023 Apr 5:rs.3.rs-2757218. [Version 1] doi: 10.21203/rs.3.rs-2757218/v1

Table 2:

Summary of adverse events

Category Total
All adverse events – no. 15
Treatment-related adverse events* – no. 4
Neutropenia 1
Decreased hemoglobin 1
Elevated liver function tests 1
Peripheral eosinophilia 1
Patients with ≥1 treatment-related adverse event – no. (%) 1 (10%)
Grade 4 adverse events – no. 4
Sports-related concussion 2
Sports-related fall and injury 1
Emergency room visit after baseline food challenge 1
Treatment-related serious adverse events – no. 0
Patients who discontinued treatment or study because of an adverse event – no. (%) 0 (0%)
*

Adverse events that were assessed as being “possibly” or “probably” related to treatment by the study investigator were recorded as being related to the study drug.